Atlas Trials

Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC

Clinical trial NCT06878274 · RECRUITING

Trial details

NCT number
NCT06878274
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung CancerStage III Lung Cancer
Start date
2026-01-29
Primary completion
2030-02-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.